nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chemotherapy at the end of life: up until when?
|
Sanz Ortiz, Jaime |
|
2012 |
14 |
9 |
p. 667-674 |
artikel |
2 |
Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients
|
Di, Lijun |
|
2012 |
14 |
9 |
p. 675-681 |
artikel |
3 |
Comments to SEOM clinical guidelines for the treatment of thyroid cancer
|
Riesco-Eizaguirre, Garcilaso |
|
2012 |
14 |
9 |
p. 709-710 |
artikel |
4 |
Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation
|
Pérez-Ruiz, Elisabeth |
|
2012 |
14 |
9 |
p. 682-688 |
artikel |
5 |
In answer to: “Comments to SEOM clinical guidelines for the treatment of thyroid cancer” by Garcilaso Riesco-Eizaguirre et al
|
Martínez Trufero, Javier |
|
2012 |
14 |
9 |
p. 711-712 |
artikel |
6 |
Incidence of hand–foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen
|
Gómez-Martin, Carlos |
|
2012 |
14 |
9 |
p. 689-697 |
artikel |
7 |
Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?
|
López-Gómez, Miriam |
|
2012 |
14 |
9 |
p. 641-658 |
artikel |
8 |
Promises and pitfalls of new technology in radiotherapy
|
Guedea, Ferran |
|
2012 |
14 |
9 |
p. 631-633 |
artikel |
9 |
Searching for Hif1-α interacting proteins in renal cell carcinoma
|
Medina Villaamil, V. |
|
2012 |
14 |
9 |
p. 698-708 |
artikel |
10 |
The association of annexin A2 and cancers
|
Zhang, Xiaohui |
|
2012 |
14 |
9 |
p. 634-640 |
artikel |
11 |
Trends in the lung cancer incidence and mortality in the Slovak and Czech Republics in the contexts of an international comparison
|
Ondrusova, Martina |
|
2012 |
14 |
9 |
p. 659-666 |
artikel |